The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global H1N1 Vaccines Market Research Report 2025
Synopsis
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global H1N1 Vaccines market was valued at US$ 4576.4 million in 2023 and is anticipated to reach US$ 5708.3 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for H1N1 Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding H1N1 Vaccines.
Report Scope
The H1N1 Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global H1N1 Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the H1N1 Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Baxter International
Sanofi
GSK
Pfizer
Mitsubishi Tanabe Pharma
Hualan Biological Engineering
Cipla
Merck
Sinovac Biotech
Segment by Type
Intramuscular Vaccines
Intranasal Vaccines
Intradermal Vaccines
Segment by Application
Influenza
Meningococcal
Cervical Cancer
Pneumococcal
Hepatitis
Measles
Mumps
Rubella
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of H1N1 Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of H1N1 Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global H1N1 Vaccines market was valued at US$ 4576.4 million in 2023 and is anticipated to reach US$ 5708.3 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for H1N1 Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding H1N1 Vaccines.
Report Scope
The H1N1 Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global H1N1 Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the H1N1 Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Baxter International
Sanofi
GSK
Pfizer
Mitsubishi Tanabe Pharma
Hualan Biological Engineering
Cipla
Merck
Sinovac Biotech
Segment by Type
Intramuscular Vaccines
Intranasal Vaccines
Intradermal Vaccines
Segment by Application
Influenza
Meningococcal
Cervical Cancer
Pneumococcal
Hepatitis
Measles
Mumps
Rubella
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of H1N1 Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of H1N1 Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 H1N1 Vaccines Market Overview
1.1 Product Overview and Scope of H1N1 Vaccines
1.2 H1N1 Vaccines Segment by Type
1.2.1 Global H1N1 Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Intramuscular Vaccines
1.2.3 Intranasal Vaccines
1.2.4 Intradermal Vaccines
1.3 H1N1 Vaccines Segment by Application
1.3.1 Global H1N1 Vaccines Market Value by Application: (2024-2030)
1.3.2 Influenza
1.3.3 Meningococcal
1.3.4 Cervical Cancer
1.3.5 Pneumococcal
1.3.6 Hepatitis
1.3.7 Measles
1.3.8 Mumps
1.3.9 Rubella
1.3.10 Others
1.4 Global H1N1 Vaccines Market Size Estimates and Forecasts
1.4.1 Global H1N1 Vaccines Revenue 2019-2030
1.4.2 Global H1N1 Vaccines Sales 2019-2030
1.4.3 Global H1N1 Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 H1N1 Vaccines Market Competition by Manufacturers
2.1 Global H1N1 Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global H1N1 Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global H1N1 Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global H1N1 Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of H1N1 Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of H1N1 Vaccines, Product Type & Application
2.7 H1N1 Vaccines Market Competitive Situation and Trends
2.7.1 H1N1 Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest H1N1 Vaccines Players Market Share by Revenue
2.7.3 Global H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 H1N1 Vaccines Retrospective Market Scenario by Region
3.1 Global H1N1 Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global H1N1 Vaccines Global H1N1 Vaccines Sales by Region: 2019-2030
3.2.1 Global H1N1 Vaccines Sales by Region: 2019-2024
3.2.2 Global H1N1 Vaccines Sales by Region: 2025-2030
3.3 Global H1N1 Vaccines Global H1N1 Vaccines Revenue by Region: 2019-2030
3.3.1 Global H1N1 Vaccines Revenue by Region: 2019-2024
3.3.2 Global H1N1 Vaccines Revenue by Region: 2025-2030
3.4 North America H1N1 Vaccines Market Facts & Figures by Country
3.4.1 North America H1N1 Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America H1N1 Vaccines Sales by Country (2019-2030)
3.4.3 North America H1N1 Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe H1N1 Vaccines Market Facts & Figures by Country
3.5.1 Europe H1N1 Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe H1N1 Vaccines Sales by Country (2019-2030)
3.5.3 Europe H1N1 Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific H1N1 Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific H1N1 Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific H1N1 Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific H1N1 Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America H1N1 Vaccines Market Facts & Figures by Country
3.7.1 Latin America H1N1 Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America H1N1 Vaccines Sales by Country (2019-2030)
3.7.3 Latin America H1N1 Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa H1N1 Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa H1N1 Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa H1N1 Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa H1N1 Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global H1N1 Vaccines Sales by Type (2019-2030)
4.1.1 Global H1N1 Vaccines Sales by Type (2019-2024)
4.1.2 Global H1N1 Vaccines Sales by Type (2025-2030)
4.1.3 Global H1N1 Vaccines Sales Market Share by Type (2019-2030)
4.2 Global H1N1 Vaccines Revenue by Type (2019-2030)
4.2.1 Global H1N1 Vaccines Revenue by Type (2019-2024)
4.2.2 Global H1N1 Vaccines Revenue by Type (2025-2030)
4.2.3 Global H1N1 Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global H1N1 Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global H1N1 Vaccines Sales by Application (2019-2030)
5.1.1 Global H1N1 Vaccines Sales by Application (2019-2024)
5.1.2 Global H1N1 Vaccines Sales by Application (2025-2030)
5.1.3 Global H1N1 Vaccines Sales Market Share by Application (2019-2030)
5.2 Global H1N1 Vaccines Revenue by Application (2019-2030)
5.2.1 Global H1N1 Vaccines Revenue by Application (2019-2024)
5.2.2 Global H1N1 Vaccines Revenue by Application (2025-2030)
5.2.3 Global H1N1 Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global H1N1 Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott H1N1 Vaccines Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Baxter International
6.2.1 Baxter International Corporation Information
6.2.2 Baxter International Description and Business Overview
6.2.3 Baxter International H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter International H1N1 Vaccines Product Portfolio
6.2.5 Baxter International Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi H1N1 Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSK H1N1 Vaccines Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer H1N1 Vaccines Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Mitsubishi Tanabe Pharma
6.6.1 Mitsubishi Tanabe Pharma Corporation Information
6.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Product Portfolio
6.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.7 Hualan Biological Engineering
6.6.1 Hualan Biological Engineering Corporation Information
6.6.2 Hualan Biological Engineering Description and Business Overview
6.6.3 Hualan Biological Engineering H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hualan Biological Engineering H1N1 Vaccines Product Portfolio
6.7.5 Hualan Biological Engineering Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Corporation Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cipla H1N1 Vaccines Product Portfolio
6.8.5 Cipla Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Merck H1N1 Vaccines Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Sinovac Biotech
6.10.1 Sinovac Biotech Corporation Information
6.10.2 Sinovac Biotech Description and Business Overview
6.10.3 Sinovac Biotech H1N1 Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sinovac Biotech H1N1 Vaccines Product Portfolio
6.10.5 Sinovac Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 H1N1 Vaccines Industry Chain Analysis
7.2 H1N1 Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 H1N1 Vaccines Production Mode & Process
7.4 H1N1 Vaccines Sales and Marketing
7.4.1 H1N1 Vaccines Sales Channels
7.4.2 H1N1 Vaccines Distributors
7.5 H1N1 Vaccines Customers
8 H1N1 Vaccines Market Dynamics
8.1 H1N1 Vaccines Industry Trends
8.2 H1N1 Vaccines Market Drivers
8.3 H1N1 Vaccines Market Challenges
8.4 H1N1 Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
